Lindenwold Advisors INC Has $2.71 Million Holdings in UnitedHealth Group Incorporated $UNH

Lindenwold Advisors INC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% in the second quarter, HoldingsChannel.com reports. The firm owned 8,691 shares of the healthcare conglomerate’s stock after acquiring an additional 240 shares during the period. UnitedHealth Group comprises 1.4% of Lindenwold Advisors INC’s investment portfolio, making the stock its 20th largest holding. Lindenwold Advisors INC’s holdings in UnitedHealth Group were worth $2,711,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the company. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the first quarter worth $42,000. Kentucky Trust Co grew its holdings in shares of UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on UNH shares. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday. JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Oppenheimer lowered their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Trading Down 3.6%

NYSE:UNH opened at $354.30 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The business’s 50-day moving average price is $318.21 and its two-hundred day moving average price is $350.41. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.38 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.